CHIRON, ORTHO FILE PATENT INFRINGEMENT CLAIM AGAINST UNITED BIOMEDICAL
This article was originally published in The Gray Sheet
Executive Summary
CHIRON, ORTHO FILE PATENT INFRINGEMENT CLAIM AGAINST UNITED BIOMEDICAL, seeking to enjoin UBI from manufacturing and selling its HCV enzyme immunoassay, which is currently pending FDA approval. "UBI's sale in the United States of HCV immunoassays employing C domain antigens covered by the claims of [Patent No. 5,350,671] will constitute knowing and willful infringement of the '671 patent," the suit charges. Chiron and joint venture partner Ortho Diagnostic Systems are plaintiffs in the case against privately held UBI.